Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Andrea R. Genazzani, Tiziana Fidecicchi, Domenico Arduini, Andrea Giannini & Tommaso Simoncini. (2023) Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice. Gynecological Endocrinology 39:1.
Read now
Read now
Katherine Sherif, Jamie Coborn, Anthony Hoovler & Lisa Gill. (2023) Medical journey of patients with polycystic ovary syndrome and obesity: a cross-sectional survey of patients and primary care physicians. Postgraduate Medicine 135:3, pages 312-320.
Read now
Read now
Edileia Bagatin, Marco Alexandre Dias da Rocha, Thais Helena Proença Freitas & Caroline Sousa Costa. (2021) Treatment challenges in adult female acne and future directions. Expert Review of Clinical Pharmacology 14:6, pages 687-701.
Read now
Read now
Giuseppe Morgante, Valentina Cappelli, Libera Troìa & Vincenzo De Leo. (2020) Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome. The European Journal of Contraception & Reproductive Health Care 25:3, pages 176-181.
Read now
Read now
Articles from other publishers (19)
Maria-Elina Mosorin, Terhi Piltonen, Anni S. Rantala, Marika Kangasniemi, Elisa Korhonen, Risto Bloigu, Juha S. Tapanainen & Laure Morin-Papunen. (2023) Oral and Vaginal Hormonal Contraceptives Induce Similar Unfavorable Metabolic Effects in Women with PCOS: A Randomized Controlled Trial. Journal of Clinical Medicine 12:8, pages 2827.
Crossref
Crossref
Sarah E. Hill & Summer Mengelkoch. (2023) Moving beyond the mean: Promising research pathways to support a precision medicine approach to hormonal contraception. Frontiers in Neuroendocrinology 68, pages 101042.
Crossref
Crossref
Varun Reddy, Megan Wurtz, Shahil H. Patel, Micheline McCarthy & Ami P. Raval. (2022) Oral contraceptives and stroke: Foes or friends. Frontiers in Neuroendocrinology 67, pages 101016.
Crossref
Crossref
Shivani Akre, Kapil Sharma, Swarupa Chakole & Mayur B Wanjari. (2022) Recent Advances in the Management of Polycystic Ovary Syndrome: A Review Article. Cureus.
Crossref
Crossref
Saheed Olanrewaju Afolabi, Joy Folahan, Olalekan Agede & Olufunke Olorundare. (2021) Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorate the Effect of Combined Oral Contraceptive- (COC-) Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats. International Journal of Reproductive Medicine 2021, pages 1-12.
Crossref
Crossref
I. V. Kuznetsova. (2021) Basic principles of diagnosis and treatment of diseases as part of hyperandrogenic syndrome. Medical alphabet:26, pages 8-13.
Crossref
Crossref
Lisa R. Sammaritano. (2021) Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS. Current Rheumatology Reports 23:6.
Crossref
Crossref
Eliza Buyers, Amy E. Sass, Cameron D. Severn, Laura Pyle & Melanie Cree-Green. (2021) Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology 34:1, pages 33-39.
Crossref
Crossref
V.Yu. Prilutskaya, O.S. Alyautdina & N.A. Sosna. (2021) The effect of the combination of myoinositol and D-chiroinositol in a ratio of 5:1 on the psychoemotional state and manifestations of androgen-dependent dermopathy in patients with polycystic ovary syndrome. Problemy reproduktsii 27:4, pages 97.
Crossref
Crossref
Angelo Cagnacci & Anna Biasioli. 2021. Female and Male Contraception. Female and Male Contraception
299
317
.
Franca Fruzzetti, Tiziana Fidecicchi & Giulia Palla. 2021. Female and Male Contraception. Female and Male Contraception
249
266
.
Susanna Hofbauer & Peter Wiesli. (2020) CME: Primäre und sekundäre Hypercholesterinämie. Praxis 109:10, pages 755-762.
Crossref
Crossref
Sarina SchragerMagnolia LarsonJensena CarlsonKathryn LedfordDeborah B. Ehrenthal. (2020) Beyond Birth Control: Noncontraceptive Benefits of Hormonal Methods and Their Key Role in the General Medical Care of Women. Journal of Women's Health 29:7, pages 937-943.
Crossref
Crossref
Teodora Onciu & Remus Şipoş. (2020) Polycystic ovary syndrome. Medic.ro 3:135, pages 44.
Crossref
Crossref
Shailaja Nair, Yolaine Nkamga & Bryson Hoover-Hankerson. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
371
386
.
Samira Behboudi-Gandevani, Hayedeh Abtahi, Navid Saadat, Maryam Tohidi & Fahimeh Ramezani Tehrani. (2019) Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial. Journal of Ovarian Research 12:1.
Crossref
Crossref
Amie Woodward, David Broom, Deborah Harrop, Ian Lahart, Anouska Carter, Caroline Dalton, Mostafa Metwally & Markos Klonizakis. (2019) The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis. Journal of Diabetes & Metabolic Disorders 18:2, pages 597-612.
Crossref
Crossref
Sasha Mikhael, Advaita Punjala-Patel & Larisa Gavrilova-Jordan. (2019) Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility. Biomedicines 7:1, pages 5.
Crossref
Crossref
Kehinde Samuel Olaniyi & Lawrence Aderemi Olatunji. (2018) Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4. Naunyn-Schmiedeberg's Archives of Pharmacology 392:1, pages 89-101.
Crossref
Crossref